POLYGYNAX VAGINAL CAPSULES
POLYGYNAX VAGINAL CAPSULES - 12PCS
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
International non-proprietary name
Neomycin + Polymyxin B + Nystatin
The active ingredients are neomycin sulfate, polymyxin B sulfate and nystatin.
Antibacterial, antifungal local. It has a bactericidal effect on Gram-positive (Staphylococcus aureus, Corynebacterium, etc.) and Gram-negative organisms (Enterococcus faecium, Enterobacter aerogenes, E. coli, Haemophilus influenzae, Proteus vulgaris, Klebsiella pneumoniae, Mycobacterium tuberculosis, Ichrophen, Ichropyne, Ichrophen I, I, I, and I can use the systems, I will be on the system I, I will have a system of Ichroma, I will have a few It has a fungicidal effect on pathogenic fungi, especially the yeast-like genus Candida albicans, Cryptococcus and Histoplasma. It is evenly distributed throughout the vaginal mucosa and is practically not absorbed from its surface.
Indications for use
Local treatment of vaginal, cervicovaginal and vulvovaginal infections (nonspecific bacterial, fungal, mixed); with prophylactic purposes before surgical intervention in the genital tract, childbirth, intrauterine devices, before and after cervical diathermocoagulation.
Allergic reaction to any component of the drug.
Allergic reactions to the components of the drug.With prolonged use, systemic manifestation of the side effects of aminoglycosides is possible.
Concurrent use with spermicides is not recommended (as a decrease in the activity of the drug is possible).
No information available.
The risk of developing an oto- and nephrotoxic effect is limited to a short course, topical administration and a low daily dose. Cross-hypersensitivity reactions to aminoglycosides are possible. In order to prevent the formation of the resistance of individual pathogens to the drug and the risk of reinfection, the time of use should be limited. Caution should be applied against the background of renal failure. It is advisable not to apply during pregnancy. When pregnancy is detected during treatment, the need for its further continuation is decided by the doctor. At the time of treatment should stop breastfeeding. You should not interrupt the course of treatment at the time of menstruation. During therapy, contraceptive caps and latex condoms should not be used. In case of missing a dose, the next one is not doubled. A wide range of action of the drug does not exclude the need for mandatory prior smear and bacteriological analysis before starting therapy.
List B. At a temperature not higher than 25 ° C.